Patents by Inventor Steven C. Springmeyer
Steven C. Springmeyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9622752Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: GrantFiled: March 6, 2015Date of Patent: April 18, 2017Assignee: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Publication number: 20160030048Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: ApplicationFiled: March 6, 2015Publication date: February 4, 2016Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Patent number: 8974527Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: GrantFiled: March 29, 2013Date of Patent: March 10, 2015Assignee: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Patent number: 8667973Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: GrantFiled: November 1, 2011Date of Patent: March 11, 2014Assignee: Spiration, Inc.Inventor: Steven C. Springmeyer
-
Patent number: 8444690Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: GrantFiled: January 12, 2011Date of Patent: May 21, 2013Assignee: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C Springmeyer, William A. Sirokman
-
Publication number: 20120101428Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: ApplicationFiled: November 1, 2011Publication date: April 26, 2012Applicant: SPIRATION, INC.Inventor: Steven C. Springmeyer
-
Patent number: 8079368Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: GrantFiled: March 10, 2010Date of Patent: December 20, 2011Assignee: Spiration, Inc.Inventor: Steven C. Springmeyer
-
Publication number: 20110208228Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: ApplicationFiled: January 12, 2011Publication date: August 25, 2011Applicant: SPIRATION, INC.Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Publication number: 20110201956Abstract: Devices, systems, and methods for diagnosing physiological parameters of the lungs and treating associated medical conditions are disclosed herein. In particular, certain embodiments permit detection of air flow in lung passageways, air leaks, gas concentration (in particular oxygen), and temperature measurements. Measurements obtained using the devices, systems, and methods disclosed herein may also be used to determine optimal treatment sites for medical conditions such as emphysema, COPD, or lung volume reduction.Type: ApplicationFiled: October 27, 2010Publication date: August 18, 2011Inventors: Clifton A. Alferness, Steven C. Springmeyer, Brandon James Shuman, William A. Sirokman, Hugo X. Gonzalez, Clinton L. Finger
-
Patent number: 7887585Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: GrantFiled: March 4, 2009Date of Patent: February 15, 2011Assignee: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Publication number: 20100256714Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: ApplicationFiled: March 10, 2010Publication date: October 7, 2010Inventor: Steven C. Springmeyer
-
Publication number: 20090182369Abstract: Systems and devices for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion device is preferably removed after the air leak has substantially permanently healed. The occluding device may be a one-way valve. The occluding device may also comprise strut members and anchors that penetrate an airway wall.Type: ApplicationFiled: March 4, 2009Publication date: July 16, 2009Applicant: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C. Springmeyer, William A. Sirokman
-
Patent number: 7533671Abstract: Methods and systems for minimally invasively treating an air leak in a lung comprise the steps of detecting an air leak in a lung; locating an airway in fluid communication with the air leak, introducing a bronchoscope into a patient's airway to a position adjacent the target section and occluding an airway upstream of the air leak for a period of time. The airway occlusion is preferably removed after the air leak has substantially permanently healed. The method can also include the injection of a substance into the airway on a distal side of the occlusion.Type: GrantFiled: December 22, 2003Date of Patent: May 19, 2009Assignee: Spiration, Inc.Inventors: Hugo Xavier Gonzalez, Steven C Springmeyer, William A. Sirokman
-
Patent number: 7100616Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: GrantFiled: April 8, 2003Date of Patent: September 5, 2006Assignee: Spiration, Inc.Inventor: Steven C. Springmeyer
-
Publication number: 20040200484Abstract: A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.Type: ApplicationFiled: April 8, 2003Publication date: October 14, 2004Inventor: Steven C. Springmeyer